VanEck Associates’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
VanEck Associates's BSX.PRA Position: Q2 2023 in Review
VanEck Associates sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 180,471 shares — an estimated $21.8M sold.
VanEck Associates first reported a position in BSX.PRA in Q3 2020 and held it in 7 quarters. The position peaked at $21.8M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- VanEck Associates reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- VanEck Associates sold 180,471 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $21.8M.
- VanEck Associates first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q3 2020 and held it in 7 quarters.
- VanEck Associates's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $21.8M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.